The Team

Ulrika Wennberg, Chief Executive Officer 
Ulrika Wennberg has more than 20 years of business experience as an entrepreneur, project manager, management consultant and business leader. She has broad experience from several different industries, including consulting, IT, media and biotech. Ulrika has worked as CFO/CEO at Jederström Pharmaceuticals AB 2007-2009, COO of Pergamum AB since 2009 and CEO of Lipopeptide AB  2013-2015. Ulrika holds a Master’s degree in Management.


Jonas Ekblom, Business Advisor 
(PhD) Jonas Ekblom has over 25 years of experience from pharmaceutical R&D. Dr. Ekblom has held senior positions at Pharmacia, Sequenom, Life Technologies, BOWS Pharmaceuticals, and Pergamum AB. He also serves on the board of several organizations, including KLIFO A/S, The Releef Initiative, and Sven Tumba Foundation. Dr. Ekblom holds an associate professorship at Uppsala University.


Håkan Nyqvist, Director Formulation Development
(PhD, Senior Lecturer Uppsala University) Håkan Nyqvist has more than 30 years of experience of drug development and licensing in large pharmaceutical companies. Dr. Nyqvist has held senior positions at Astra AB, ACO Läkemedel AB, Pharmacia and AstraZeneca.

Ninus Caram-Lelham, Director CMC
(PhD, Pharmaceutical Chemistry) Ninus Caram-Lelham has more than 15 years of experience working with drug development in the pharmaceutical industry. Dr. Caram-Lelham has held the position of  Chemical Pharmaceutical Assessor at the Medical Products Agency (MPA), as well as various positions at pharmaceutical and medical device companies, such as Pharmacia & Upjohn, Q-Med AB, Aprea AB and Clanotech AB.


Ann-Sofie Sternås, Senior Patent Attorney EPA, Director Intellectual Property
(European Patent Attorney, MSc Chemical Engineering) Ann-Sofie Sternås has almost 20 years of IP experience from large pharmaceutical companies and has held senior IPR positions within Astra and AstraZeneca. For many years, Ms. Sternås was heavily involved in IP litigation relating to several blockbuster drugs. Ms. Sternås is specialized in IP-strategic matters with a heavy focus on US legislation, particularly IP in the interface between patent law and regulatory law.


Maria Klockare, Director Clinical Operations
(BSc) Maria Klockare has 15 years of experience in the pharmaceutical industry as Project Manager, Clinical Project Leader, and Clinical Research Associate at companies including AstraZeneca, BMS, Sanofi-Aventis, Creative Peptides, Trial Form Support, Eli Lilly, Quintiles, PPD, UCB Pharma, Roche, and CSL Behring.